Iterum Therapeutics Plc (ITRM) Tops Q4 EPS by 8c

Iterum Therapeutics Plc (NASDAQ: ITRM) reported Q4 EPS of ($0.11), $0.08 better than the analyst estimate of ($0.19).

For earnings history and earnings-related data on Iterum Therapeutics Plc (ITRM) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• FactSet Research Systems (FDS) PT Raised to $253 at Jefferies
• Isabella Bank added to Russell 2000 index after Nasdaq listing